Skip to contentY
Yubo International Biotech Ltd
Y
YBGJYubo International Biotech Ltd Q4 2013 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$0.00$0.00derivedno prior Q4 2012 on file Net Income-$28.00K-$28.00KderivedN/M vs Q4 2012 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Yubo International Biotech Ltd · CIK 895464 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$14,000N/M Operating Cash Flowderived-$7,000N/M ended Feb 28, 2014 · filed Jun 6, 2014 · 98 d after period end